Clearikon Health Introduces Innovative Wound Care Solutions
Clearikon Health, a UF Innovate | Accelerate alumni company, continues to revolutionize equine healthcare with the launch of innovative wound care products.
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
Solid Biosciences Inc., a life sciences company that acquired UF startup AavantiBio, announced that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SGT-212, the Company’s, AAV-based gene therapy candidate for the treatment of Friedreich’s ataxia (FA).
Solid Biosciences Announces FDA IND Clearance for First-in-Industry Dual Route of Administration Gene Therapy To Treat Both Neurologic and Cardiac Manifestations of Friedreich’s Ataxia
Solid Biosciences Inc., a biotechnology company that acquired UF startup AavantiBio, announced that the U.S. FDA has cleared its Investigational New Drug application for SGT-212 for the treatment of Friedreich’s ataxia.
New Study Shows Shoplifting Is Up 93% Since Before the COVID-19 Pandemic
UF startup LPRC conducted a study to examine how theft and violence have evolved since before COVID-19. The study revealed a significant increase in both the average number of shoplifting incidents and the dollars lost due to shoplifting.
Portage Biotech Announces Letter of Intent With Immunova for an Option To Acquire iOx Therapeutics, Ltd
UF startup Immunova, LLC, a private Connecticut-based biotechnology company, has entered into a Letter of Intent with Portage Biotech, Inc. to advance its novel immuno-oncology therapies for cancer treatment.
RTI Surgical Transforms Into Evergen, a Leading CDMO in Regenerative Medicine
UF startup RTI Surgical unveils its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.
How Atsena Got Its Gene Therapy To Spread Subretinally To Treat XLRS
UF researcher Sanford Boye, co-founder and adviser of UF Startup Atsena Therapeutics, shared insights into how the company developed its gene therapy to achieve subretinal spread for treating XLRS.
InStore.ai Partners With Loss Prevention Resource Council
InStore.ai, a pioneer in voice-driven business optimization for the retail industry, has entered into a strategic partnership with UF Innovate | Accelerate client Loss Prevention Research Council.
Solid Biosciences Announces Collaboration With Mayo Clinic To Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene Therapies
Solid Biosciences Inc., which acquired UF Startup AavantiBio, has partnered with Mayo Clinic to advance an AAV gene therapy platform for next-generation treatments targeting genetic cardiomyopathies and channelopathies linked to sudden cardiac death.
Theft and Crime Are Driving Retail Workers To Look for New Roles, Joint Study From the Loss Prevention Research Council and Verkada Finds
According to research conducted by UF Innovate | Accelerate client Loss Prevention Research Council in collaboration with Verkada, over 40% of retail workers in the U.S. are considering leaving their jobs within the next year due to concerns about personal safety.